SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
yuanyuanyuanyuan
Lv1
10 积分
2023-02-06 加入
最近求助
最近应助
互助留言
Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials
1个月前
已完结
Donanemab for Alzheimer Disease—Who Benefits and Who Is Harmed?
1个月前
已完结
Donanemab in Early Symptomatic Alzheimer Disease
1个月前
已完结
Apparent changes in the epidemiology and severity of multiple sclerosis
3个月前
已完结
Diagnosis and Treatment of Multiple Sclerosis
3个月前
已完结
Efficacy of oral tofacitinib in refractory chronic spontaneous urticaria and urticarial vasculitis
6个月前
已完结
Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management
6个月前
已完结
Abrocitinib effect on patient‐reported outcomes in patients with moderate‐to‐severe atopic dermatitis: Results from phase 3 studies, including the long‐term extension JADE EXTEND study
10个月前
已完结
Bimekizumab maintenance of response through three years in patients with moderate to severe plaque psoriasis: Results from the BE BRIGHT open-label extension trial
10个月前
已完结
Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis
11个月前
已完结
没有进行任何应助
感谢,速度真快,点赞
1个月前
感谢,点赞,速度真快,帮大忙了,么么哒
3个月前
速度真快,点赞,感谢
6个月前
感谢,速度真快,帮大忙了,点赞
6个月前
感谢,点赞,速度真快,帮大忙了
10个月前
感谢,点赞,速度真快,帮大忙了
10个月前
速度真快,点赞,感谢
11个月前
谢谢您的帮助
1年前
感谢,速度真快,点赞
1年前
感谢,点赞
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论